Anaphylactic shock: are we doing enough and with the right timing and order?

1. KEMP SF, LOCKEY RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol. Sep. 2002; 110(3):341-8.Search in Google Scholar

2. ALRASBI M, SHEIKH A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy. Aug. 2007; 62(8):838-41.Search in Google Scholar

3. LAIDMAN J. Anaphylaxis requires prompt epinephrine shot. Medscape Medical News [serial online]. December 3, 2014; Accessed December 6, 2014. Available at http://www.medscape.com/viewarticle/835786.Search in Google Scholar

4. CAMPBELL RL, LI JT, NICKLAS RA, SADOSTY AT. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. Dec. 2014; 113(6):599-608.Search in Google Scholar

5. WORKING GROUP OF THE RESUSCITATION COUNCIL (UK). Emergency treatment of anaphylactic reactions: guidelines for healthcare providers. 2008.Search in Google Scholar

6. ELLIS AK, DAY JH. Diagnosis and management of anaphylaxis. CMAJ 2003; 169:307-11.Search in Google Scholar

7. AMERICAN HEART ASSOCIATION. GUIDELINES FOR CARDIOPULMONARY RESUSCITATION AND EMERGENCY CARDIOVASCULAR CARE: PART 10.6: Anaphylaxis. Circulation 2005; 112:143-5.Search in Google Scholar

8. SIMONS FE. Anaphylaxis pathogenesis and treatment. Allergy. Jul. 2011; 66 Suppl 95:31-4.10.1111/j.1398-9995.2011.02629.xSearch in Google Scholar

9. PUMPHREY RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol. Aug. 2003; 112(2):451-2.10.1067/mai.2003.1614Search in Google Scholar

10. ACUTE CARE UNDERGRADUATE TEACHING (ACUTE) INITIATIVE. A joint publication from the Resuscitation Council (UK) and Intercollegiate Board for Training in Intensive Care Medicine. 2005.Search in Google Scholar

11. O’DRISCOLL BR, HOWARD LS, DAVISON AG. BTS guideline for emergency oxygen use in adult patients. Thorax 2008; 63 (Suppl 6):vi1-68.10.1136/thx.2008.102947Search in Google Scholar

12. NURMATOV U, WORTH A, SHEIKH A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol. Aug. 2008; 122(2):353-61, 361.e1-3.Search in Google Scholar

13. LIEBERMAN P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol. Aug. 2003; 3(4):313-8.10.1097/00130832-200308000-00013Search in Google Scholar

14. KEMP SF, LOCKEY RF, SIMONS FE. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy. Aug. 2008; 63(8):1061-70.Search in Google Scholar

15. SHEIKH A, SHEHATA YA, BROWN SGA, SIMONS FER. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock. Cochrane Data Syst Rev 2008; 4:CD006312, doi:10.1002/14651858.CD006312.pub2Search in Google Scholar

16. BRAGANZA SC, ACWORTH JP, MCKINNON DR, PEAKE JE, BROWN AF. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child. Feb. 2006; 91(2):159-63.Search in Google Scholar

17. YONG P. F. K., BIRNS J., IBRAHIM M. A. A. Anaphylactic shock: the great mimic. South Med. J. 2007; 100 (3): 295-297.Search in Google Scholar

18. HAUSMANN O, SCHNYDER B, PICHLER WJ. Drug hypersensitivity reactions involving skin. Handb Exp Pharmacol. 2010; 196:29-5510.1007/978-3-642-00663-0_2Search in Google Scholar

19. FRIEDMANN P. S., ARDERN-JONES M. Patch testing in drug Allergy. Curr. Opin. Allergy Clin. Immunol. 2010; 10 (4): 291.Search in Google Scholar

20. SIMONS FE, ARDUSSO LR, BILÒ MB, EL-GAMAL YM, LEDFORD DK, RING J, et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. Mar. 2011; 127(3):587-93.e1-22.10.1016/j.jaci.2011.01.038Search in Google Scholar

21. LIEBERMAN P, NICKLAS RA, OPPENHEIMER J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. Sep. 2010; 126(3):477-80.e1-42.10.1016/j.jaci.2010.06.022Search in Google Scholar

22. JOHANSSON SG, BIEBER T, DAHL R, FRIEDMANN PS, LANIER BQ, LOCKEY RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. May 2004; 113(5):832-6.Search in Google Scholar

23. KEMP SF, LOCKEY RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002; 110:341-34810.1067/mai.2002.126811Search in Google Scholar

24. AKIN C. Anaphylaxis and mast cell disease: what is the risk? Curr Allergy Asthma Rep. Jan. 2010; 10(1):34-8.Search in Google Scholar

25. DYKEWICZ MS. Anaphylaxis and inflammation. Clin Allergy Immunol 2002; 16:401-409.Search in Google Scholar

26. KEMP SF. Current concepts in pathophysiology, diagnosis, and management of anaphylaxis. Immunol Allergy Clin North Am 2001; 21:611-63410.1016/S0889-8561(15)30004-7Search in Google Scholar

27. VADAS P, GOLD M, PERELMAN B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med. Jan. 3 2008; 358(1):28-35.Search in Google Scholar

28. NEUGUT AI, GHATAK AT, MILLER RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 2001; 161:15-21.10.1001/archinte.161.1.15Search in Google Scholar

29. YOCUM MW, KHAN DA. Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clin Proc 1994; 69:16-23.10.1016/S0025-6196(12)61606-1Search in Google Scholar

30. DECKER WW, CAMPBELL RL, MANIVANNAN V, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol. Dec. 2008; 122(6):1161-5.Search in Google Scholar

31. LIEBERMAN P. Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol. Aug. 2008; 8(4):316-20.Search in Google Scholar

32. GREENBERGER PA. Idiopathic anaphylaxis. Immunol Allergy Clin North Am. May 2007; 27 (2):273-93, vii-viii.10.1016/j.iac.2007.03.00917493503Search in Google Scholar

33. WANG J, SAMPSON HA. Food anaphylaxis. Clin Exp Allergy. May 2007; 37(5):651-60.Search in Google Scholar

34. HOURIHANE JO'B, KILBURN SA, NORDLEE JA, HEFLE SL, TAYLOR SL, WARNER JO. An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J Allergy Clin Immunol. Nov. 1997; 100(5):596-600.Search in Google Scholar

35. BOYCE JA, ASSA'AD A, BURKS AW, JONES SM, SAMPSON HA, WOOD RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. Dec. 2010; 126(6 Suppl):S1-58.10.1016/j.jaci.2010.10.007424196421134576Search in Google Scholar

36. GOLDEN DB, MOFFITT J, NICKLAS RA, FREEMAN T, GRAFT DF, REISMAN RE, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol. Apr. 2011; 127(4):852-4.e1-2310.1016/j.jaci.2011.01.02521458655Search in Google Scholar

37. RUEFF F, PRZYBILLA B, BILO MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. Nov. 2009; 124(5):1047-54.Search in Google Scholar

38. TORRES MJ, BLANCA M, FERNANDEZ J, et al, ENDA; EAACI Interest Group on Drug Hypersensitivity. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58:961-972.10.1034/j.1398-9995.2003.00280.x14510712Search in Google Scholar

39. JOHNSON K. Antibiotics common cause of perioperative anaphylaxis. Medscape Medical News [serial online]. November 22, 2013; Accessed December 3, 2013. Available at http://www.medscape.com/viewarticle/814903.Search in Google Scholar

40. DAULAT S, SOLENSKY R, EARL HS, CASEY W, GRUCHALLA RS. Safety of cephalosporin administration to patients with histories of penicillin allergy. J Allergy Clin Immunol. Jun. 2004; 113(6):1220-2.Search in Google Scholar

41. PICHICHERO ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics. Apr. 2005; 115(4):1048-57.10.1542/peds.2004-127615805383Search in Google Scholar

42. DEMOLY P, ROMANO A, BOTELHO C, et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy. 2010; 65:327-332.10.1111/j.1398-9995.2009.02228.x19860790Search in Google Scholar

43. OWNBY DR. A history of latex allergy. J Allergy Clin Immunol 2002; 110:S27-S32.10.1067/mai.2002.12533612170240Search in Google Scholar

44. BAUER X. Epidemiology of latex sensitization. J Allergy Clin Immunol 2003; 111:652.10.1067/mai.2003.10912642856Search in Google Scholar

45. MERTES PM, MALINOVSKY JM, JOUFFROY L, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol. 2011; 21(6):442-53.Search in Google Scholar

46. AMIN HS, LISS GM, BERNSTEIN DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol. Jan. 2006; 117(1):169-75.Search in Google Scholar

47. 47.BERNSTEIN DI, WANNER M, BORISH L, LISS GM. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol. Jun. 2004; 113(6):1129-36.Search in Google Scholar

48. LOCKEY RF, BENEDICT LM, TURKELTAUB PC, BUKANTZ SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol. Apr. 1987; 79(4):660-77.Search in Google Scholar

49. LEE S, HESS EP, NESTLER DM, BELLAMKONDA ATHMARAM VR, BELLOLIO MF, DECKER WW, et al. Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis. J Allergy Clin Immunol. Apr. 2013; 131(4):1103-8.Search in Google Scholar

50. BOGGS W. Anaphylaxis worse with antihypertensive medication. Medscape Medical News. March 21, 2013. Available at http://www.medscape.com/viewarticle/781274.Search in Google Scholar

51. KATAYAMA H, YAMAGUCHI K, KOZUKA T, TAKASHIMA T, SEEZ P, MATSUURA K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.Radiology. Jun. 1990; 175(3):621-8.Search in Google Scholar

52. GREENBERGER PA, PATTERSON R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol. Apr. 1991; 87(4):867-72.Search in Google Scholar

53. SLATER JE, RAPHAEL G, CUTLER GB JR, LORIAUX DL, MEGGS WJ, KALINER M. Recurrent anaphylaxis in menstruating women: treatment with a luteinizing hormone-releasing hormone agonist – a preliminary report. Obstet Gynecol. Oct. 1987; 70(4):542-6.Search in Google Scholar

54. KEMP SF. The post-anaphylaxis dilemma: how long is long enough to observe a patient after resolution of symptoms? Curr Allergy Asthma Rep. Mar. 2008; 8(1):45-8.Search in Google Scholar

55. POSADAS SJ, PICHLER WJ. Delayed drug hypersensitivity reactions – new concepts. Clin Exp Allergy. 2007; 37:989-999.10.1111/j.1365-2222.2007.02742.x17581192Search in Google Scholar

56. LIEBERMAN PL. Specific and idiopathic anaphylaxis: pathophysiology and treatment. In: Bierman CW, Pearlman DS, Shapiro GG, et al., eds. Allergy, Asthma and Immunology From Infancy to Adulthood. Third edition. Philadelphia, WB Saunders, 1996, pp. 297-319.Search in Google Scholar

57. SIMONS FE, SAMPSON HA. Anaphylaxis epidemic: fact or fiction? J Allergy Clin Immunol. Dec. 2008; 122(6):1166-8.Search in Google Scholar

58. MONERET-VAUTRIN DA, MORISSET M, FLABBEE J, BEAUDOUIN E, KANNY G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. Apr. 2005; 60(4):443-51.Search in Google Scholar

59. DEMUTH KA, FITZPATRICK AM. Epinephrine autoinjector availability among children with food allergy. Allergy Asthma Proc. Jul. 2011; 32(4):295-300.Search in Google Scholar

60. JOSE R, CLESHAM GJ. Survey of the use of epinephrine (adrenaline) for anaphylaxis by junior hospital doctors. Postgrad Med J 2007; 83:610-1.10.1136/pgmj.2007.059097260000917823230Search in Google Scholar